Cargando…

Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments

Fungal endophthalmitis is one of the leading causes of vision loss worldwide. Post-operative and traumatic injuries are major contributing factors resulting in ocular fungal infections in healthy and, more importantly, immunocompromised individuals. Among the fungal pathogens, the Aspergillus specie...

Descripción completa

Detalles Bibliográficos
Autores principales: Khambati, Alisha, Wright, Robert Emery, Das, Susmita, Pasula, Shirisha, Sepulveda, Alejandro, Hernandez, Francis, Kanwar, Mamta, Chandrasekar, Pranatharthi, Kumar, Ashok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318612/
https://www.ncbi.nlm.nih.gov/pubmed/35887412
http://dx.doi.org/10.3390/jof8070656
_version_ 1784755336124563456
author Khambati, Alisha
Wright, Robert Emery
Das, Susmita
Pasula, Shirisha
Sepulveda, Alejandro
Hernandez, Francis
Kanwar, Mamta
Chandrasekar, Pranatharthi
Kumar, Ashok
author_facet Khambati, Alisha
Wright, Robert Emery
Das, Susmita
Pasula, Shirisha
Sepulveda, Alejandro
Hernandez, Francis
Kanwar, Mamta
Chandrasekar, Pranatharthi
Kumar, Ashok
author_sort Khambati, Alisha
collection PubMed
description Fungal endophthalmitis is one of the leading causes of vision loss worldwide. Post-operative and traumatic injuries are major contributing factors resulting in ocular fungal infections in healthy and, more importantly, immunocompromised individuals. Among the fungal pathogens, the Aspergillus species, Aspergillus fumigatus, continues to be more prevalent in fungal endophthalmitis patients. However, due to overlapping clinical symptoms with other endophthalmitis etiology, fungal endophthalmitis pose a challenge in its diagnosis and treatment. Hence, it is critical to understand its pathobiology to develop and deploy proper therapeutic interventions for combating Aspergillus infections. This review highlights the different modes of Aspergillus transmission and the host immune response during endophthalmitis. Additionally, we discuss recent advancements in the diagnosis of fungal endophthalmitis. Finally, we comprehensively summarize various antifungal regimens and surgical options for the treatment of Aspergillus endophthalmitis.
format Online
Article
Text
id pubmed-9318612
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93186122022-07-27 Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments Khambati, Alisha Wright, Robert Emery Das, Susmita Pasula, Shirisha Sepulveda, Alejandro Hernandez, Francis Kanwar, Mamta Chandrasekar, Pranatharthi Kumar, Ashok J Fungi (Basel) Review Fungal endophthalmitis is one of the leading causes of vision loss worldwide. Post-operative and traumatic injuries are major contributing factors resulting in ocular fungal infections in healthy and, more importantly, immunocompromised individuals. Among the fungal pathogens, the Aspergillus species, Aspergillus fumigatus, continues to be more prevalent in fungal endophthalmitis patients. However, due to overlapping clinical symptoms with other endophthalmitis etiology, fungal endophthalmitis pose a challenge in its diagnosis and treatment. Hence, it is critical to understand its pathobiology to develop and deploy proper therapeutic interventions for combating Aspergillus infections. This review highlights the different modes of Aspergillus transmission and the host immune response during endophthalmitis. Additionally, we discuss recent advancements in the diagnosis of fungal endophthalmitis. Finally, we comprehensively summarize various antifungal regimens and surgical options for the treatment of Aspergillus endophthalmitis. MDPI 2022-06-22 /pmc/articles/PMC9318612/ /pubmed/35887412 http://dx.doi.org/10.3390/jof8070656 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Khambati, Alisha
Wright, Robert Emery
Das, Susmita
Pasula, Shirisha
Sepulveda, Alejandro
Hernandez, Francis
Kanwar, Mamta
Chandrasekar, Pranatharthi
Kumar, Ashok
Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments
title Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments
title_full Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments
title_fullStr Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments
title_full_unstemmed Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments
title_short Aspergillus Endophthalmitis: Epidemiology, Pathobiology, and Current Treatments
title_sort aspergillus endophthalmitis: epidemiology, pathobiology, and current treatments
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318612/
https://www.ncbi.nlm.nih.gov/pubmed/35887412
http://dx.doi.org/10.3390/jof8070656
work_keys_str_mv AT khambatialisha aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments
AT wrightrobertemery aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments
AT dassusmita aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments
AT pasulashirisha aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments
AT sepulvedaalejandro aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments
AT hernandezfrancis aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments
AT kanwarmamta aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments
AT chandrasekarpranatharthi aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments
AT kumarashok aspergillusendophthalmitisepidemiologypathobiologyandcurrenttreatments